PTC Therapeutics, Inc. logo PTCT - PTC Therapeutics, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 16
HOLD 8
SELL 2
STRONG
SELL 0
| PRICE TARGET: $98.00 DETAILS
HIGH: $120.00
LOW: $82.00
MEDIAN: $94.00
CONSENSUS: $98.00
UPSIDE: 42.42%

Profitability Ratios

Ratio Value
GP Margin 95.9%
EBIT Margin 49.0%
EBITDA Margin 51.3%
Operating Margin 49.5%
Pretax Margin 40.3%
Cont. Ops Margin 39.4%
Net Margin 39.4%
Bottom Line Margin 39.4%

Liquidity Ratios

Ratio Value
Current Ratio 2.35
Quick Ratio 2.27
Solvency Ratio 0.231
Cash Ratio 1.02

Valuation Ratios

Ratio Value
Price/Earnings
8.85
Hist. avg: 8.2
Peers avg: 41.1
PEG Ratio -0.03
Forward PEG -0.03
Price/Book -29.43
Price/Sales 3.49
Price/FCF 8.60
Price/Op Cash Flow 8.49

Debt Ratios

Ratio Value
Debt/Assets 0.1691
Debt/Equity -2.3977
Debt/Capital 1.7155
Long-Term Debt/Capital -0.8376
Financial Leverage -14.18

Cash Flow Ratios

Ratio Value
Working Capital Turnover 1.66
Operating Cash Flow Ratio 0.734
Operating Cash Flow/Sales 41.1%
Free Cash Flow/Operating Cash Flow 98.8%

Coverage Ratios

Ratio Value
Debt Service Coverage 1.92
Interest Coverage 5.6264
Short-Term Operating Cash Flow Coverage 2.35
Operating Cash Flow Coverage 1.44
Capital Expenditure Coverage 80.27
Dividend + Capital Expenditure Coverage 80.27

Dividend Ratios

Ratio Value
Payout Ratio 0.0000%
Dividend Yield 0.0000%
Dividend Yield % 0.0000%
Dividend Per Share 0.0000

Per Share Ratios

Ratio Value
Revenue/Share 21.76
EPS 8.583
Debt/Share 8.1036
Cash/Share 24.46
Book Value/Share -2.58
Tangible BV/Share -8.50
Equity/Share -2.58
Operating Cash Flow/Share 8.942
Capital Expenditure/Share 0.111
FCF/Share 8.831

Other Ratios

Ratio Value
Net Income/Earnings Before Tax 0.980
Earnings Before Tax/EBIT 0.813
Price/Fair Value -29.43
Debt/Market Cap 0.0655
Effective Tax Rate 2.0%
Enterprise Value Multiple 6.25